Maxim Group Downgrades Quest Diagnostics (DGX) to Hold
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $231.97 --0%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 25
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 25
Join SI Premium – FREE
Maxim Group downgraded Quest Diagnostics (NYSE: DGX) from Buy to Hold.
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $47.03 yesterday.
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $47.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Downgrades BOK Financial (BOKF) to Underweight
- JPMorgan Downgrades XPeng (H-Shares) (9868:HK) (XPEV) to Neutral
- Goldman Sachs Downgrades China Coal Energy Co Ltd. (H-Shares) (1898:HK) (CCOZY) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Maxim GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
